Axonics, Inc.
DelistedCIK 1603756fmd_19ST3XQFCSYBW5ATQWYEN60C37Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2024, 29 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 1 | 14 | 112 | 180 | 274 | 366 |
| Cost of revenue | 0 | 0 | 6 | 44 | 65 | 76 | 92 |
| Gross profit | 0 | 0 | 7 | 67 | 116 | 198 | 275 |
| Research and development | 12 | 19 | 20 | 29 | 37 | 34 | 35 |
| Selling, general and administrative | 6 | 13 | 68 | 92 | 136 | 196 | 235 |
| Total operating expenses | 18 | 32 | 88 | 121 | 188 | 263 | 301 |
| Operating income | (18) | (32) | (81) | (54) | (72) | (65) | (26) |
| Interest and investment income | – | – | – | 1 | 0 | 5 | 17 |
| Other non-operating income (expense) | 0 | (0) | 1 | (1) | (7) | 3 | 17 |
| Income before taxes | (18) | (32) | (80) | (55) | (79) | (62) | (9) |
| Income tax expense | 0 | 0 | 0 | 0 | 1 | (3) | (3) |
| Net income from continuing operations | (18) | (32) | (80) | (55) | (80) | (60) | (6) |
| Net income | (18) | (32) | (80) | (55) | (80) | (60) | (6) |